Prescribing HIV Pre-Exposure Prophylaxis

PrEP is Pre-Exposure Prophylaxis for HIV. It is the use of antiretroviral medication to prevent HIV infection. PrEP can be used by HIV-uninfected individuals who are at risk of HIV infection either through sexual exposure or injection drug use.

PrEP has been approved by Health Canada; the drugs used for PrEP are tenofovir disoproxil fumarate and emtricitabine (TDF/FTC), which is available combined in a single tablet. This medication is available in a generic form in Ontario and is approved for use as PrEP.

Comprehensive guidance on when and how to prescribe PrEP is available at Clinicians can also request training on PrEP prescribing at the site, and a CME accredited online course on prescribing HIV PrEP is available, as well.

Canadian guidelines for HIV PrEP and PEP (post-exposure prophylaxis) are available.

For more information on PrEP and HIV testing, see Ontario Guidelines for Providers offering HIV Testing – HIV Testing Ontario.